{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:53:31Z","timestamp":1791186811783,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118470","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:40:59Z","timestamp":1789141259000},"page":"118470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling"],"prefix":"10.1016","volume":"254","author":[{"given":"Hnin Ei Ei","family":"Khine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3223-1551","authenticated-orcid":false,"given":"Supachoke","family":"Mangmool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-2477","authenticated-orcid":false,"given":"Warisara","family":"Parichatikanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.118470_b0005","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118470_b0010","article-title":"Mitochondrial dysfunction in heart failure and its therapeutic implications","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118470_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.119.044205","article-title":"Inhibition of mTOR signaling enhances maturation of cardiomyocytes derived from human-induced pluripotent stem cells via p53-induced quiescence","volume":"141","author":"Garbern","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118470_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yjmcc.2016.01.005","article-title":"Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals","volume":"95","author":"Tan","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118470_b0025","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118470_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.775507","article-title":"The cross talk between p53 and mTOR pathways in response to physiological and genotoxic stresses","volume":"9","author":"Cui","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118470_b0035","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00018-020-03694-6","article-title":"The regulatory roles of p53 in cardiovascular health and disease","volume":"78","author":"Men","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118470_b0040","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/nu15102259","article-title":"p53 at the crossroads between doxorubicin-induced cardiotoxicity and resistance: a nutritional balancing act","volume":"15","author":"Guo","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118470_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4619720","article-title":"Reperfusion therapy with rapamycin attenuates myocardial infarction through activation of AKT and ERK","volume":"2017","author":"Filippone","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0050","first-page":"195","article-title":"Rapamycin regulates the balance betweencardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling","volume":"45","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118470_b0060","article-title":"PGC-1\u03b1-mediated mitochondrial quality control: Molecular mechanisms and implications for heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0065","first-page":"32","article-title":"Mitochondrial quality control in human health and disease","volume":"11","author":"Liu","year":"2024","journal-title":"Mil. Med. Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118470_b0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2026.118470_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118470_b0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2026.118470_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7176282","article-title":"Mechanisms and drug intervention for doxorubicin-induced cardiotoxicity based on mitochondrial bioenergetics","volume":"2022","author":"Ling","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.bcp.2026.118470_b0090","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1111\/jcmm.15305","article-title":"Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions","volume":"24","author":"Osataphan","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"21","key":"10.1016\/j.bcp.2026.118470_b0095","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1158\/0008-5472.CAN-07-1344","article-title":"The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy","volume":"67","author":"Bien","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118470_b0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/toxics13040277","article-title":"Pathophysiology of doxorubicin-mediated cardiotoxicity","volume":"13","author":"Arrigoni","year":"2025","journal-title":"Toxics"},{"issue":"7","key":"10.1016\/j.bcp.2026.118470_b0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tcm.2008.11.005","article-title":"Cardioprotective signaling by endothelin","volume":"18","author":"Schorlemmer","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The importance of endothelin-1 for vascular dysfunction in cardiovascular disease","volume":"76","author":"B\u00f6hm","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118470_b0115","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1517\/14656560903061275","article-title":"Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension","volume":"10","author":"Kingman","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"issue":"22","key":"10.1016\/j.bcp.2026.118470_b0120","doi-asserted-by":"crossref","first-page":"13816","DOI":"10.3390\/ijms232213816","article-title":"High glucose-induced cardiomyocyte damage involves interplay between endothelin ET-1\/ETA\/ETB receptor and mTOR pathway","volume":"23","author":"Pandey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0125","doi-asserted-by":"crossref","first-page":"14850","DOI":"10.1038\/s41598-026-44822-9","article-title":"Ambrisentan attenuates cisplatin-related mitochondrial dysfunction in the heart via regulation of p53 and NF-\u03baB signaling","volume":"16","author":"Khine","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118470_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1055911","article-title":"MicroRNAs in doxorubicin-induced cardiotoxicity: the DNA damage response","volume":"13","author":"Kawano","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118470_b0135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jat.70131","article-title":"Doxorubicin-induced cardiotoxicity: Comprehensive pathway insights and advanced preclinical therapeutics","volume":"46","author":"Sharma","year":"2026","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118470_b0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbamcr.2014.11.015","article-title":"H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation","volume":"1853","author":"Kuznetsov","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118470_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178233","article-title":"Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-\u03baB pathways","volume":"1007","author":"Khine","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118470_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116175","article-title":"Stimulation of adenosine A1 receptor prevents oxidative injury in H9c2 cardiomyoblasts: Role of G\u03b2\u03b3-mediated Akt and ERK1\/2 signaling","volume":"451","author":"Mangmool","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118470_b0155","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/acsptsci.5c00760","article-title":"Dapagliflozin protects cardiomyocytes against doxorubicin-induced toxicity by modulating sirtuin 1\/sirtuin 3 and ferroptosis pathway","volume":"9","author":"Khine","year":"2026","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2026.118470_b0160","article-title":"Bosentan confers cardioprotection against cisplatin toxicity: Involvement of \u03b2-arrestin-linked ETA receptor signaling","volume":"250","author":"Khine","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118470_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116552","article-title":"Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: potential role of GLP-1 receptor and mTOR signaling","volume":"229","author":"Parichatikanond","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118470_b0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.pharmtox.41.1.851","article-title":"Endothelin system: the double-edged sword in health and disease","volume":"41","author":"Kedzierski","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118470_b0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-005-1999-2","article-title":"Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion","volume":"275","author":"Gupta","year":"2005","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118470_b0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/jmcc.1996.0054","article-title":"Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart","volume":"28","author":"Wang","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118470_b0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0706050","article-title":"Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia\/reperfusion injury via the ETA receptor and the mitochondrial KATP channel in the rat in vivo","volume":"144","author":"Gourine","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/FJC.0000000000000758","article-title":"Activation of cannabinoid receptors attenuates endothelin-1-induced mitochondrial dysfunction in rat ventricular myocytes","volume":"75","author":"Lu","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118470_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7845629","article-title":"The endothelin receptor antagonist macitentan improves isosorbide-5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) induced endothelial dysfunction, oxidative stress, and vascular inflammation","volume":"2018","author":"Steven","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bcp.2026.118470_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70006","article-title":"Dual ETA-ETB receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fraction","volume":"39","author":"Lockwood","year":"2025","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118470_b0205","article-title":"Astaxanthin protects against H2O2- and doxorubicin-induced cardiotoxicity in H9c2 rat myocardial cells","volume":"14","author":"Krestinin","year":"2024","journal-title":"Life (Basel)"},{"issue":"18","key":"10.1016\/j.bcp.2026.118470_b0210","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","article-title":"Inhibiting mitochondrial fission protects the heart against ischemia\/reperfusion injury","volume":"121","author":"Ong","year":"2010","journal-title":"Circulation"},{"issue":"7334","key":"10.1016\/j.bcp.2026.118470_b0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09787","article-title":"Telomere dysfunction induces metabolic and mitochondrial compromise","volume":"470","author":"Sahin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118470_b0220","article-title":"Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes acute liver injury induced by heat stroke","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118470_b0225","article-title":"Harpagoside protects against doxorubicin-induced cardiotoxicity via p53-Parkin-mediated mitophagy","volume":"10","author":"Li","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118470_b0230","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118470_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1616235","article-title":"Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes","volume":"13","author":"Ke","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118470_b0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/biom12020299","article-title":"RRM2 alleviates doxorubicin-induced cardiotoxicity through the AKT\/mTOR signaling pathway","volume":"12","author":"Jiao","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.bcp.2026.118470_b0245","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/MCB.22.8.2799-2809.2002","article-title":"Akt\/protein kinase B promotes organ growth in transgenic mice","volume":"22","author":"Shioi","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cvr\/cvv252","article-title":"Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy","volume":"109","author":"Shende","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.118470_b0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2016.04.011","article-title":"mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53\/JNK-mediated apoptosis","volume":"97","author":"Mazelin","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118470_b0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/hrt.2006.089250","article-title":"Clinical trials of endothelin antagonists in heart failure: Publication is good for the public health","volume":"93","author":"Kelland","year":"2007","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.bcp.2026.118470_b0265","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2026.118470_b0270","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/Y10-041","article-title":"Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1","volume":"88","author":"Kelland","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:19:18Z","timestamp":1791184758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"alternative-id":["S0006295226008105"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118470","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118470"}}